279 related articles for article (PubMed ID: 10673637)
1. [Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors].
Spaëth D; Geoffrois L; Conroy T
Bull Cancer; 2000 Jan; 87(1):93-6. PubMed ID: 10673637
[No Abstract] [Full Text] [Related]
2. Managing hematologic toxicities.
Capo G; Waltzman R
J Support Oncol; 2004; 2(1):65-79. PubMed ID: 15330374
[TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
de la Rubia Comos J
Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
[No Abstract] [Full Text] [Related]
4. [Hematopoietic growth factors: past, present, future].
Blay JY
Bull Cancer; 2006 May; 93(5):429. PubMed ID: 16777619
[No Abstract] [Full Text] [Related]
5. [Myelosuppression due to antineoplastic agents].
Shigeoka Y; Shimizu E
Nihon Rinsho; 2007 Oct; 65 Suppl 8():287-93. PubMed ID: 18074550
[No Abstract] [Full Text] [Related]
6. Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?
Croockewit AJ; Koopmans PP; de Pauw BE
Clin Pharmacol Ther; 1996 Jan; 59(1):1-6. PubMed ID: 8549028
[No Abstract] [Full Text] [Related]
7. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).
Lieschke GJ; Burgess AW
N Engl J Med; 1992 Jul; 327(2):99-106. PubMed ID: 1376442
[No Abstract] [Full Text] [Related]
8. Clinical needs for hematopoietic growth factors: old and new.
Rusthoven JJ
Cancer Invest; 1996; 14(6):622-34. PubMed ID: 8951365
[No Abstract] [Full Text] [Related]
9. Granulocyte colony-stimulating factors.
Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
[No Abstract] [Full Text] [Related]
10. Growth factor frenzy.
Quesenberry PJ
Exp Hematol; 1993 Jul; 21(7):835-6. PubMed ID: 7686499
[No Abstract] [Full Text] [Related]
11. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
12. [Myelotoxicity due to chemotherapy in oncology practice].
Geoffrois L
Rev Prat; 2006 Nov; 56(18):2009-14. PubMed ID: 17274503
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
[TBL] [Abstract][Full Text] [Related]
14. The American Society of Clinical Oncology guideline program.
Winn RF; Smith TF
Pharm Pract Manag Q; 1996 Apr; 16(1):31-8. PubMed ID: 10157738
[No Abstract] [Full Text] [Related]
15. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
16. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
[No Abstract] [Full Text] [Related]
17. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
18. Hematopoietic growth factors as supportive therapy for cancer- and chemotherapy-induced conditions.
Symann M
Curr Opin Oncol; 1991 Aug; 3(4):648-55. PubMed ID: 1932223
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic use of hematopoietic growth factors.
Costa JJ
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
[No Abstract] [Full Text] [Related]
20. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
